Paul Matteis
Stock Analyst at Stifel Nicolaus
(4.51)
# 1,068
Out of 5,036 analysts
749
Total ratings
44.9%
Success rate
9.8%
Average return
Main Sectors:
Stocks Rated by Paul Matteis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALKS Alkermes | Reiterated: Buy | $63 | $41.45 | +52.01% | 60 | Oct 5, 2026 | |
| LXEO Lexeo Therapeutics | Reiterated: Buy | $17 | $3.32 | +412.05% | 10 | Oct 5, 2026 | |
| CTNM Contineum Therapeutics | Reiterated: Buy | $28 | $12.74 | +119.78% | 13 | Sep 30, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $37 | $15.97 | +131.68% | 29 | Sep 30, 2026 | |
| QURE uniQure | Reiterated: Buy | n/a | $23.14 | - | 28 | Sep 29, 2026 | |
| VRTX Vertex Pharmaceuticals | Reiterated: Hold | n/a | $505.64 | - | 44 | Sep 22, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | n/a | $36.41 | - | 30 | Sep 18, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $56 | $30.86 | +81.46% | 12 | Sep 16, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $60 → $67 | $35.09 | +90.94% | 8 | Sep 15, 2026 | |
| SION Sionna Therapeutics | Reiterated: Hold | $7 | $4.82 | +45.23% | 6 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $43 | $31.65 | +35.86% | 1 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $318 | $224.41 | +41.70% | 50 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $70 | $55.20 | +26.81% | 47 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $11.69 | +79.64% | 8 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $53 | $34.16 | +55.15% | 4 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $25.90 | +77.61% | 25 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $2.40 | +400.00% | 18 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $17.93 | +67.32% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $19.16 | +113.99% | 29 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $38 | $21.06 | +80.44% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 | $19.65 | +27.23% | 51 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $214 → $242 | $222.15 | +8.94% | 52 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $86 → $68 | $44.16 | +53.99% | 33 | Aug 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $188 → $215 | $143.47 | +49.86% | 55 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.2471 | +304.69% | 8 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 | $88.45 | +50.37% | 12 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $36 | $9.36 | +284.62% | 4 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.63 | +227.65% | 3 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $0.4683 | +540.61% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $23.52 | +40.31% | 10 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.92 | - | 12 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.10 | +376.19% | 9 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.83 | n/a | 11 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $10.72 | n/a | 11 | Jun 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $3.54 | n/a | 13 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $11 → $20 | $61.18 | n/a | 4 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.0001 | n/a | 1 | Aug 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $20 | $0.0001 | n/a | 4 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.57 | n/a | 1 | Nov 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.15 | n/a | 4 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.0001 | n/a | 3 | May 19, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $7 | $0.7914 | n/a | 2 | May 6, 2016 |
Alkermes
Oct 5, 2026
Reiterated: Buy
Price Target: $63
Current: $41.45
Upside: +52.01%
Lexeo Therapeutics
Oct 5, 2026
Reiterated: Buy
Price Target: $17
Current: $3.32
Upside: +412.05%
Contineum Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: $28
Current: $12.74
Upside: +119.78%
Dyne Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: $37
Current: $15.97
Upside: +131.68%
uniQure
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $23.14
Upside: -
Vertex Pharmaceuticals
Sep 22, 2026
Reiterated: Hold
Price Target: n/a
Current: $505.64
Upside: -
Xenon Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $36.41
Upside: -
Rapport Therapeutics
Sep 16, 2026
Reiterated: Buy
Price Target: $56
Current: $30.86
Upside: +81.46%
Definium Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $60 → $67
Current: $35.09
Upside: +90.94%
Sionna Therapeutics
Sep 15, 2026
Reiterated: Hold
Price Target: $7
Current: $4.82
Upside: +45.23%
Sep 14, 2026
Initiated Coverage: Buy
Price Target: $43
Current: $31.65
Upside: +35.86%
Aug 31, 2026
Reiterated: Buy
Price Target: $318
Current: $224.41
Upside: +41.70%
Aug 31, 2026
Reiterated: Hold
Price Target: $70
Current: $55.20
Upside: +26.81%
Aug 13, 2026
Reiterated: Buy
Price Target: $21
Current: $11.69
Upside: +79.64%
Aug 13, 2026
Reiterated: Buy
Price Target: $40 → $53
Current: $34.16
Upside: +55.15%
Aug 13, 2026
Reiterated: Buy
Price Target: $46
Current: $25.90
Upside: +77.61%
Aug 13, 2026
Reiterated: Buy
Price Target: $12
Current: $2.40
Upside: +400.00%
Aug 13, 2026
Reiterated: Buy
Price Target: $30
Current: $17.93
Upside: +67.32%
Aug 7, 2026
Reiterated: Buy
Price Target: $41
Current: $19.16
Upside: +113.99%
Aug 6, 2026
Reiterated: Buy
Price Target: $32 → $38
Current: $21.06
Upside: +80.44%
Aug 5, 2026
Reiterated: Hold
Price Target: $25
Current: $19.65
Upside: +27.23%
Aug 2, 2026
Reiterated: Buy
Price Target: $214 → $242
Current: $222.15
Upside: +8.94%
Aug 2, 2026
Reiterated: Hold
Price Target: $86 → $68
Current: $44.16
Upside: +53.99%
Jul 31, 2026
Reiterated: Buy
Price Target: $188 → $215
Current: $143.47
Upside: +49.86%
Jul 6, 2026
Reiterated: Hold
Price Target: $1
Current: $0.2471
Upside: +304.69%
Jun 15, 2026
Reiterated: Buy
Price Target: $133
Current: $88.45
Upside: +50.37%
Jun 2, 2026
Reiterated: Buy
Price Target: $28 → $36
Current: $9.36
Upside: +284.62%
May 28, 2026
Reiterated: Buy
Price Target: $25
Current: $7.63
Upside: +227.65%
May 12, 2026
Reiterated: Hold
Price Target: $3
Current: $0.4683
Upside: +540.61%
Apr 2, 2026
Reiterated: Buy
Price Target: $33
Current: $23.52
Upside: +40.31%
Dec 22, 2025
Rated: Hold
Price Target: n/a
Current: $1.92
Upside: -
Dec 16, 2025
Reiterated: Buy
Price Target: $10
Current: $2.10
Upside: +376.19%
Sep 19, 2024
Rated: Hold
Price Target: n/a
Current: $5.83
Upside: n/a
Jun 3, 2023
Reiterated: Buy
Price Target: $5
Current: $10.72
Upside: n/a
May 12, 2022
Reiterated: Hold
Price Target: $3
Current: $3.54
Upside: n/a
Feb 28, 2022
Downgraded: Hold
Price Target: $11 → $20
Current: $61.18
Upside: n/a
Aug 16, 2017
Initiated Coverage: Buy
Price Target: $18
Current: $0.0001
Upside: n/a
Mar 10, 2017
Reiterated: Buy
Price Target: $14 → $20
Current: $0.0001
Upside: n/a
Nov 23, 2016
Reiterated: Buy
Price Target: n/a
Current: $2.57
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $2.15
Upside: n/a
May 19, 2016
Reiterated: Buy
Price Target: $11
Current: $0.0001
Upside: n/a
May 6, 2016
Reiterated: Hold
Price Target: $14 → $7
Current: $0.7914
Upside: n/a